Fat-soluble statins linked to lower odds of Parkinson's

07/25/2013 | HealthDay News

Patients who stopped taking fat-soluble statins had a 58% greater risk of developing Parkinson's disease than those who continued taking the cholesterol-lowering drugs, according to a study of almost 44,000 people. The rate of Parkinson's disease was about double among patients who took water-soluble statins compared with those treated with fat-soluble statins. The findings appear in the journal Neurology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ